List of Excipients in API atropine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing atropine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Meridian Medical Technologies LLC | ATROPEN AUTO-INJECTOR | atropine | 11704-107 | CITRIC ACID MONOHYDRATE | |
| Meridian Medical Technologies LLC | ATROPEN AUTO-INJECTOR | atropine | 11704-107 | NITROGEN | |
| Meridian Medical Technologies LLC | ATROPEN AUTO-INJECTOR | atropine | 11704-107 | SODIUM CHLORIDE | |
| Meridian Medical Technologies LLC | ATROPEN AUTO-INJECTOR | atropine | 11704-107 | SODIUM CITRATE | |
| Meridian Medical Technologies LLC | ATROPEN AUTO-INJECTOR | atropine | 11704-107 | WATER | |
| Alcon Laboratories Inc | ISOPTO ATROPINE | atropine sulfate | 0065-0303 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | ISOPTO ATROPINE | atropine sulfate | 0065-0303 | BORIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing atropine
Detailed excipient profiles for atropine
Excipient focus: BENZALKONIUM CHLORIDE
atropine drug variants containing BENZALKONIUM CHLORIDE
atropine drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: BENZYL ALCOHOL
atropine drug variants containing BENZYL ALCOHOL
atropine drug variants not containing BENZYL ALCOHOL
Excipient focus: BORIC ACID
atropine drug variants containing BORIC ACID
atropine drug variants not containing BORIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
atropine drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Meridian Medical Technologies LLC | atropine | 11704-107 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: EDETATE DISODIUM
atropine drug variants containing EDETATE DISODIUM
atropine drug variants not containing EDETATE DISODIUM
Excipient focus: EDETATE SODIUM
atropine drug variants containing EDETATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Somerset Therapeutics LLC | atropine sulfate | 70069-581 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing EDETATE SODIUM
Excipient focus: HYDROCHLORIC ACID
atropine drug variants containing HYDROCHLORIC ACID
atropine drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
atropine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | atropine sulfate | 0065-0817 |
| Bausch & Lomb Incorporated | atropine sulfate | 24208-965 |
| Bausch & Lomb Americas Inc | atropine sulfate | 82260-001 |
| Somerset Therapeutics LLC | atropine sulfate monohydrate | 70069-716 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
atropine drug variants containing HYPROMELLOSE 2910
atropine drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
atropine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | atropine sulfate | 0065-0303 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing HYPROMELLOSES
Excipient focus: NITROGEN
atropine drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Meridian Medical Technologies LLC | atropine | 11704-107 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing NITROGEN
Excipient focus: SODIUM CHLORIDE
atropine drug variants containing SODIUM CHLORIDE
atropine drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
atropine drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Meridian Medical Technologies LLC | atropine | 11704-107 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
atropine drug variants containing SODIUM HYDROXIDE
atropine drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM PHOSPHATE, DIBASIC
atropine drug variants containing SODIUM PHOSPHATE, DIBASIC
atropine drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
atropine drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Lifestar Pharma LLC | atropine sulfate | 70756-651 |
| NorthStar RxLLC | atropine sulfate | 72603-264 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
atropine drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Somerset Therapeutics LLC | atropine sulfate | 70069-581 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
atropine drug variants containing SODIUM PHOSPHATE, MONOBASIC
atropine drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
atropine drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Somerset Therapeutics LLC | atropine sulfate | 70069-581 |
| Lifestar Pharma LLC | atropine sulfate | 70756-651 |
| NorthStar RxLLC | atropine sulfate | 72603-264 |
| >Company | >Ingredient | >NDC |
atropine drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Excipient focus: SULFURIC ACID
atropine drug variants containing SULFURIC ACID
atropine drug variants not containing SULFURIC ACID
Excipient focus: WATER
atropine drug variants containing WATER
atropine drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
